Home Neoplasma Ahead of print neo_2020_190616N513

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

neo_2020_190616N513

Title: Association of interlukine-18 polymorphisms with susceptibility to prostate cancer in Iranian population
Author: M. ABEDINZADEH, M. GHODSIAN, S. A. DASTGHEIB, J. JAFARI-NEDOOSHAN, M. ZARE, N. HEIRANIZADEH, A. RAEE-EZZABADI, H. NEAMATZADEH

Abstract: Interleukin-18 (IL-18) is a multifunctional cytokine that augments interferon-γ production, promotion of the Th1 immune response and acts as an important immunomediator in the development of some cancers. The current study aimed to analyze the association of five most common polymorphisms in IL-18 gene with prostate cancer in Iranian population.
We examined a possible association of IL-18 -137G>C, -607C>A, -656G>T, +105A>C and +127C>T polymorphisms with prostate cancer occurrence by PCR-RFLP assay. Odds ratio (OR) and 95% confidence interval (CI) were used to assess the strength of the association between IL-18 polymorphisms and prostate cancer. Statistical analysis revealed that individuals carrying the mutant homozygote genotype of IL-18 -607C>A (OR  =  2.251, 95% CI  =  1.062-4.768, P = 0.034) and -137G>C (OR  =  2.364, 95% CI  =  1.121-4.984, P = 0.024) polymorphisms had an increased risk of prostate cancer. However, for IL-18 -656G>T, +105A>C and +127C>T polymorphisms, there were no differential distributions of their genotypes between patients with prostate cancer and healthy subjects. Our results indicated that the IL-18 -137G>C and -607C>A polymorphisms were significantly associated with an increased risk of prostate cancer in Iranian population. Thus, these polymorphisms might be used as a molecular biomarker in the early diagnosis of prostate cancer.

Keywords:
Published online: 10-Feb-2020
Year: , Volume: , Issue: Page From: , Page To:
doi:10.4149/neo_2020_190616N513


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.